Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.
66% more capital invested
Capital invested by funds: $666M → $1.1B (+$438M)
19% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 37
2% more funds holding
Funds holding: 200 → 204 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 69
68% less call options, than puts
Call options by funds: $8.85M | Put options by funds: $27.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$54.4M |
| 2 |
Renaissance Technologies
New York
|
+$36.7M |
| 3 |
PC
PointState Capital
New York
|
+$16.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.79M |
| 5 |
Goldman Sachs
New York
|
+$6.89M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$16.4M |
| 2 |
ClearBridge Investments
New York
|
-$14.7M |
| 3 |
O
OrbiMed
New York
|
-$13.1M |
| 4 |
Millennium Management
New York
|
-$12.9M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$11.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
226
Pacer Advisors
Malvern,
Pennsylvania
| – | -$42K | -6,532 | Closed |
|
|
IWP
227
Icon Wealth Partners
Houston,
Texas
| – | -$24K | -3,718 | Closed |
|
|
BL
228
Balentine LLC
Atlanta,
Georgia
| – | -$12K | -1,902 | Closed |
|
|
RWA
229
Ropes Wealth Advisors
Boston,
Massachusetts
| – | -$6K | -915 | Closed |
|
|
MA
230
MUFG Americas
New York
| – | -$2K | -273 | Closed |
|
|
KJWM
231
Kiley Juergens Wealth Management
Olympia,
Washington
| – | -$1K | -213 | Closed |
|
|
II
232
Inspire Investing
Meridian,
Idaho
| – | -$1K | -198 | Closed |
|
|
WAM
233
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$1K | -179 | Closed |
|
|
IWM
234
IHT Wealth Management
Chicago,
Illinois
| – | -$1K | -154 | Closed |
|
|
JFGIW
235
Johnson Financial Group Inc (Wisconsin)
Racine,
Wisconsin
| – | -$1K | -130 | Closed |
|
|
MSA
236
Marino Stram & Associates
Braintree,
Massachusetts
| – | -$1K | -100 | Closed |
|
|
CB
237
CNB Bank
Clearfield,
Pennsylvania
| – | -$1K | -89 | Closed |
|
|
AC
238
Avestar Capital
New York
| – | +$612 | +62 | +6% |
|
IMGN Hedge Fund Activity: Q1 2018 in Review
204 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2018, worth a combined $1.1B — up 66% from $666M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new IMGN positions and 37 closed out — a net gain of 7 holders — while 59 added to existing stakes and 69 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $54.4M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $16.4M sold.
- 204 institutional investors held Immunogen Inc (IMGN) as of Q1 2018, up from 200 in Q4 2017.
- Funds reported $1.1B of Immunogen Inc stock for Q1 2018, up 66% quarter-over-quarter.
- 44 funds opened new Immunogen Inc positions in Q1 2018 and 37 closed out, a net change of +7 holders.
- The largest Immunogen Inc buyer in Q1 2018 was Capital Research Global Investors, an estimated $54.4M added.
- The largest Immunogen Inc seller in Q1 2018 was Baker Bros. Advisors, an estimated $16.4M sold.
Based on aggregated 13F filings for Q1 2018.